Introducing the Fiberoptic Microneedle Device (FMD), a cutting-edge solution at the forefront of cancer treatment innovation. This device is designed to revolutionize Plasmonic Photothermal Therapy (PPTT), offering a superior approach to combat pancreatic cancer – a disease characterized by limited treatment options. This pioneering Fiberoptic Microneedle Device not only promises an advanced treatment modality but also introduces a potential breakthrough in the fight against pancreatic cancer, addressing the need for more selective and efficient therapeutic options.
